483 related articles for article (PubMed ID: 15846641)
1. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.
Empson M; Lassere M; Craig J; Scott J
Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002859. PubMed ID: 15846641
[TBL] [Abstract][Full Text] [Related]
2. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.
Bala MM; Paszek E; Lesniak W; Wloch-Kopec D; Jasinska K; Undas A
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012534. PubMed ID: 30004572
[TBL] [Abstract][Full Text] [Related]
4. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
de Jong PG; Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD004734. PubMed ID: 24995856
[TBL] [Abstract][Full Text] [Related]
6. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials.
Empson M; Lassere M; Craig JC; Scott JR
Obstet Gynecol; 2002 Jan; 99(1):135-44. PubMed ID: 11777524
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome.
Di Nisio M; Peters L; Middeldorp S
Cochrane Database Syst Rev; 2005 Apr; (2):CD004734. PubMed ID: 15846729
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight heparin or LMWH plus aspirin in the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: A meta-analysis of randomized controlled trial.
Yan X; Wang D; Yan P; Li H
Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():22-30. PubMed ID: 34794071
[TBL] [Abstract][Full Text] [Related]
9. Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis.
Yang Z; Shen X; Zhou C; Wang M; Liu Y; Zhou L
Lupus; 2021 Jan; 30(1):70-79. PubMed ID: 33081590
[TBL] [Abstract][Full Text] [Related]
10. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis.
Ziakas PD; Pavlou M; Voulgarelis M
Obstet Gynecol; 2010 Jun; 115(6):1256-1262. PubMed ID: 20502298
[TBL] [Abstract][Full Text] [Related]
11. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
Rai R; Cohen H; Dave M; Regan L
BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome-What is the evidence?
Hamulyák EN; Scheres LJJ; Goddijn M; Middeldorp S
J Thromb Haemost; 2021 May; 19(5):1174-1185. PubMed ID: 33687789
[TBL] [Abstract][Full Text] [Related]
13. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
Areia AL; Fonseca E; Areia M; Moura P
Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
[TBL] [Abstract][Full Text] [Related]
14. Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials.
Lu C; Liu Y; Jiang HL
J Matern Fetal Neonatal Med; 2019 Apr; 32(8):1299-1311. PubMed ID: 29179589
[TBL] [Abstract][Full Text] [Related]
15. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis.
Roberge S; Demers S; Nicolaides KH; Bureau M; Côté S; Bujold E
Ultrasound Obstet Gynecol; 2016 May; 47(5):548-53. PubMed ID: 26481090
[TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.
van Hoorn ME; Hague WM; van Pampus MG; Bezemer D; de Vries JI;
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():168-73. PubMed ID: 26771908
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
Noble LS; Kutteh WH; Lashey N; Franklin RD; Herrada J
Fertil Steril; 2005 Mar; 83(3):684-90. PubMed ID: 15749498
[TBL] [Abstract][Full Text] [Related]
18. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
Sandercock PA; Counsell C; Tseng MC
Cochrane Database Syst Rev; 2008 Jul; (3):CD000119. PubMed ID: 18646059
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
Backos M; Rai R; Baxter N; Chilcott IT; Cohen H; Regan L
Br J Obstet Gynaecol; 1999 Feb; 106(2):102-7. PubMed ID: 10426674
[TBL] [Abstract][Full Text] [Related]
20. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
